Table 3 Outcomes stratified by tranexamic acid administration
Total (n = 71) | TXA (n = 14) | No TXA (n = 57) | P-value | |
|---|---|---|---|---|
Underwent cranial decompression, n | 31 (43.7%) | 7 (50.0%) | 24 (42.1%) | 0.76 |
Field GCS | 11.8 ± 3.8 | 9.2 ± 4.4 | 12.5 ± 3.4 | 0.008* |
Discharge GCS | 13.7 ± 3.4 | 13.3 ± 4.0 | 13.8 ± 3.2 | 0.58 |
Change in GCS | 1.8 ± 3.4 | 3.7 ± 3.9 | 1.3 ± 3.1 | 0.02* |
6-month GOS | 3.7 ± 1.0 | 3.5 ± 0.9 | 3.8 ± 1.0 | 0.13 |
Mortality, n | 5 (7.0%) | 1 (7.1%) | 4 (7.0%) | 1.0 |